| 000 | 01631 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516224408.0 | ||
| 264 | 0 | _c20150330 | |
| 008 | 201503s 0 0 eng d | ||
| 022 | _a1873-2518 | ||
| 024 | 7 |
_a10.1016/j.vaccine.2014.07.051 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOreshkova, N | |
| 245 | 0 | 0 |
_aEvaluation of nonspreading Rift Valley fever virus as a vaccine vector using influenza virus hemagglutinin as a model antigen. _h[electronic resource] |
| 260 |
_bVaccine _cSep 2014 |
||
| 300 |
_a5323-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Intranasal |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Viral _xblood |
| 650 | 0 | 4 |
_aAntigens, Viral _ximmunology |
| 650 | 0 | 4 |
_aCytokines _ximmunology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemagglutinin Glycoproteins, Influenza Virus _ximmunology |
| 650 | 0 | 4 |
_aImmunoglobulin G _xblood |
| 650 | 0 | 4 | _aInfluenza A Virus, H1N1 Subtype |
| 650 | 0 | 4 |
_aInfluenza Vaccines _ximmunology |
| 650 | 0 | 4 | _aInjections, Intramuscular |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aOrthomyxoviridae Infections _xprevention & control |
| 650 | 0 | 4 |
_aReplicon _ximmunology |
| 650 | 0 | 4 |
_aRift Valley fever virus _ximmunology |
| 650 | 0 | 4 |
_aTh1 Cells _ximmunology |
| 650 | 0 | 4 |
_aVaccination _xmethods |
| 700 | 1 | _aCornelissen, L A H M | |
| 700 | 1 | _ade Haan, C A M | |
| 700 | 1 | _aMoormann, R J M | |
| 700 | 1 | _aKortekaas, J | |
| 773 | 0 |
_tVaccine _gvol. 32 _gno. 41 _gp. 5323-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2014.07.051 _zAvailable from publisher's website |
| 999 |
_c24046949 _d24046949 |
||